
ARGX vs MRNA
$ARGX vs $MRNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ARGX vs MRNA: the quick read
- ·ARGX is the larger company by market cap ($61.96B vs $61.50B).
- ·MRNA has been more active on our scanner (334 vs 36 alerts in 30 days).
- ·ARGX has the smaller float (61.9M vs 354.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·MRNA trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·MRNA draws far more of our scanner's attention, 334 unusual-volume alerts in 30 days against 36, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both are trading in the upper quarter of their 52-week range, so neither is a pullback candidate right now.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ARGX and MRNA on TheDesperateTrader.
- Is ARGX or MRNA the better stock?
- "Better" depends on your goal, and these two are not alike. ARGX is the larger company by market cap ($61.96B vs $61.50B). MRNA has been more active on our scanner (334 vs 36 alerts in 30 days). ARGX has the smaller float (61.9M vs 354.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ARGX and MRNA?
- The differences that matter: they are not in the same business - ARGX is biological products, (no diagnostic substances) and MRNA is biological products, (no diagnostic substances); they are similar in size ($61.96B vs $61.50B); they trade at very different share prices ($990.32 vs $153.87); ARGX sits at 80% of its 52-week range against 85% for MRNA; our scanner flagged ARGX 36 times in the last 30 days against 334 for MRNA. Everything above is measured from the latest completed session and SEC filings.
- Which of ARGX and MRNA is more active right now?
- Right now ARGX is at about 0.9x its normal volume and MRNA is at about 0.8x, so ARGX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ARGX or MRNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ARGX and MRNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.